NLRP3 and diabetic kidney disease: Another study suggests that CD36 mediates NLRP3 inflammasome activation via suppressing mitochondrial fatty acid oxidation (FAO) and stimulating mitochondrial reactive oxygen species (mtROS) production in DKD (Hou et al., 2021).